LetterLetter
Dr. Gunderson et al reply
Tina M. Gunderson, Elena Myasoedova, John M. Davis III and Cynthia S. Crowson
The Journal of Rheumatology April 2022, jrheum.211343; DOI: https://doi.org/10.3899/jrheum.211343
Tina M. Gunderson
Department of Quantitative Health Sciences; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. This work was funded by grants from the National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Disease (R01 AR46849), and National Institute of Aging (NIA; R01 AG068192). Research reported in this publication was supported by the NIA of the NIH under Award Number R01AG034676. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. C.S. Crowson, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA. Email: crowson@mayo.edu.
Elena Myasoedova
Department of Quantitative Health Sciences; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. This work was funded by grants from the National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Disease (R01 AR46849), and National Institute of Aging (NIA; R01 AG068192). Research reported in this publication was supported by the NIA of the NIH under Award Number R01AG034676. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. C.S. Crowson, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA. Email: crowson@mayo.edu.
John M. Davis III
Department of Quantitative Health Sciences; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. This work was funded by grants from the National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Disease (R01 AR46849), and National Institute of Aging (NIA; R01 AG068192). Research reported in this publication was supported by the NIA of the NIH under Award Number R01AG034676. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. C.S. Crowson, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA. Email: crowson@mayo.edu.
Cynthia S. Crowson
Department of Quantitative Health Sciences; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. This work was funded by grants from the National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Disease (R01 AR46849), and National Institute of Aging (NIA; R01 AG068192). Research reported in this publication was supported by the NIA of the NIH under Award Number R01AG034676. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. C.S. Crowson, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905, USA. Email: crowson@mayo.edu.

Abstract
We thank Drs. Liao, Liao, and Liaw for their interest in our article on multimorbidity burden in patients with rheumatoid arthritis (RA).1 We agree that not all morbidities were included in the assessment of multimorbidity in our article, and further research is warranted to more comprehensively assess multimorbidity in patients with RA.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 6
1 Jun 2022
Dr. Gunderson et al reply
Tina M. Gunderson, Elena Myasoedova, John M. Davis, Cynthia S. Crowson
The Journal of Rheumatology Apr 2022, jrheum.211343; DOI: 10.3899/jrheum.211343